PARP Inhibitor–Based Combinations to Improve Patient Outcomes in Prostate Cancer: An Evidence-Based Global Perspective

Learn about PARP inhibitor&ndash based combination therapy in prostate cancer in this expert-authored online activity with downloadable slides podcasts and a ClinicalThought.

Share

Program Content

Activities

PARPi Combos in Prostate Cancer
Novel PARP Inhibitor–Based Combinations Targeting Improved Patient Outcomes in Prostate Cancer
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: April 12, 2021

Expires: April 11, 2022

Activities

PARPi Combinations in Prostate Cancer
My Thoughts on Expanding the Role of PARP Inhibitors in Prostate Cancer With Combination Therapy
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: January 25, 2021

Expires: January 24, 2022

前立腺がんにおけるPARPi の組み合わせ療法
前立腺がんの組み合わせ治療におけるPARP阻害薬の役割拡大に関する自分の考え
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: March 02, 2021

Expires: March 01, 2022

PARPi-Kombinationen bei Prostatakrebs
Meine Überlegungen zur Ausweitung der Rolle von PARP-Inhibitoren bei Prostatakrebs mit der Kombinationstherapie
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: March 02, 2021

Expires: March 01, 2022

Combinazioni PARPi nel cancro alla prostata
Opinione sullespansione del ruolo degli inibitori PARP nel cancro alla prostata con terapia combinate
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: March 02, 2021

Expires: March 01, 2022

Associations thérapeutiques utilisant des inhibiteurs de la PARP pour le traitement du cancer de la prostate
Ma réflexion sur lélargissement du rôle des inhibiteurs de la PARP en combinaison pour le traitement du cancer de la prostate
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022
Combinaciones PARPi en el cáncer de próstata
Mis consideraciones sobre la expansión del papel de los inhibidores PARP en el cáncer de próstata con terapia de combinación
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Activities

Rationale: PARPi Combinations
Rationale for Combining PARP Inhibitors With Other Therapies in Prostate Cancer
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: April 15, 2021

Expires: April 14, 2022

<i>Pearls</i>: Combination Therapy Rationale
Podcast Pearls: Rationale for Combining PARP Inhibitors With Other Therapies in Prostate Cancer
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: April 16, 2021

Expires: April 15, 2022

Prostate Ca: PARPi Trials
Combining PARP inhibitors With Other Treatments for Men With Prostate Cancer: Clinical Trial Updates
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: April 19, 2021

Expires: April 18, 2022

<i>Pearls</i>: PARPi Combo Trials
Podcast Pearls: Combining PARP inhibitors With Other Treatments for Men With Prostate Cancer: Clinical Trial Updates
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: April 19, 2021

Expires: April 18, 2022

Activities

PARPi Combinations in mCRPC
PARP Inhibitor–Based Combinations to Improve Patient Outcomes in Prostate Cancer: An Evidence-Based Global Perspective
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: April 12, 2021

Expires: April 11, 2022

Faculty

cover img faculity

Karim Fizazi, MD, PhD

Full Professor
Cancer Medicine
Gustave Roussy
Villejuif, France

cover img faculity

Joaquin Mateo, MD, PhD

Medical Oncology Department
Vall d’Hebron University Hospital
Group Leader
Vall d’Hebron Institute of Oncology
Barcelona, Spain

cover img faculity

Charles Ryan, MD

Associate Clinical Professor
Department of Medicine Hematology/Oncology
University of California, San Francisco
San Francisco, California

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

Pfizer, Inc.